|
Note: Not all studies are available based
on copyrights of the original documents. Please
note the PARI Pharma copyright studies are
owned by PARI Pharma. Data may not be referenced in any
way including print and electronic formats
without the prior written consent of PARI Pharma.
M. Griese, C. Eismann, M. Kappler, H. Mazurk, A. Ameal-Godoy, T. Hunger, O. Denk,J. Schierholz, S. Prante, M. Keller Randomized, Open Labeled, Multi Center, Active Controlled, Parallel 28 Days Safety and Bioavailability Study of Tobramycin T100 PARI Nebulized with eFlow® Versus TOBI® Nebulized With PARI LC PLUS® in 76 Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa Infections
23rd Annual North American (NACF), Minneapolis, Minnesota, USA, October 15-17, 2009 |
 |
C. Fuchs, B. Eschrich, L. Huck, R. Pokorski, W. Achtzehner, S. Seemann, C. Eismann, M. Greise, M. Knoch
An Investigational Patient Monitoring System to Generate Objective Information on Patients’ Drug Adherence to Inhaled Medications
23rd Annual North American (NACF), Minneapolis, Minnesota, USA, October 15-17, 2009 |
|
O. Denk, M. Keller, S. Prante, F. Gruber, C. Fuchs, M. Knoch
Rationale for Low Dose Liposomal Cyclosporin A for Inhalation Via a Customized eFlow® Electronic Nebulizer to Prevent and Treat Bronchiolitis Obliterans (BO)
23rd Annual North American (NACF), Minneapolis, Minnesota, USA, October 15-17, 2009 |
|
U. Schuschnig, A. Kruener, M. Keller Characterization of Paranasal Devices in a Human Nasal Cast – Do In-Vitro Data Support Promises?
23rd Annual North American (NACF), Minneapolis, Minnesota, USA, October 15-17, 2009 |
|
M. Keller, O. Denk, E. Corbanie, U. Fleschhut, S. Maresch, A. Bucholski, U. Schuschnig, M. Knoch
Aerosol Characterization of Novel Stabilized Liquid Inhalation Solutions Containing up to 100mg Azithromycin/ml for Nebulization via Electronic Nebulizers for Home and Hospital Use Based on the eFlow® Vibrating Membrane Technology
23rd Annual North American (NACF), Minneapolis, Minnesota, USA, October 15-17, 2009 |
|
[ECFC 06-09 14] M. Keller, O. Denk, R. Egle, F. Gruber, E. Brendel, U. Fleschhut, H. Leuchte, J. Behr
RATIONALE FOR A LOW DOSE LIPOSOMAL CICLOSPORIN A FOR INHALATION VIA A CUSTOMIZED eFLOW® ELECTRONIC NEBULIZER TO PREVENT AND TREAT BRONCHIOLITIS OBLITERANS (BO)
ECCF Conference, June 10-12, 2009, Brest, France |
|
[ECFC 06-09 13] O. Denk, A.L. Coates, K. Leung, M. Green, J. Chan, N. Ribeiro, M. Charron and M. Keller
LUNG DELIVERY OF A NEW TOBRAMYCIN NEBULISER SOLUTION (150 MG/1.5 ML) BY AN INVESTIGATIONAL eFLOW® NEBULISER IS EQUIVALENT TO TOBI® BUT IN A FRACTION OF TIME
ECCF Conference, June 10-12, 2009, Brest, France |
|
[ATS 05-09 11] Schuschnig Uwe, Krüner Axel, Keller Manfred
Characterization of Paranasal Drug Delivery Devices Utilizing a Human Nasal Cast Does In Vitro Data Support Promises?
American Thoracic Society, ATS 2009, Annual Meeting,San Diego, CA, USA, May 15th - 20h, 2009 |
|
[ATS 05-09 10] Keller M, Egle R, Hug M, Bitterle E, Bucholski A, Spescha H, Möller A, Knauer N, Inci D, and Wildhaber J
Aerosol Characterization of Higher Concentrated Cromoglycate Solutions Delivered via a Small Droplet Size eFlow® Nebulizer for the Treatment of Allergic Asthma
American Thoracic Society, ATS 2009, Annual Meeting,San Diego, CA, USA, May 15th - 20h, 2009 |
|
[ISAM 05-09 09] Keller M, Egle R, Hug M, Bitterle E, Bucholski A, Spescha H, Möller A, Knauer N, Inci D, and Wildhaber J
Novel Therapeutic Perspectives of Di-Sodium-Cromo-Glycate (DSCG) Using an Investigational Small Droplet eFlow® Electronic Nebulizer
International Society for Aerosols in Medicine, ISAM 2009, 17th congress, Monterey, CA, USA, May 10th - 14h, 2009
|
|
[ISAM 05-09 08] Hahn M, Tservistas M, Hetzer U, Seidler A, Grieblinger E, Keller M, and Knoch M
In Vitro Assessment of a Novel Nebulizer for Mechanically Ventilated Patients Based on the eFlow® Technology
International Society for Aerosols in Medicine, ISAM 2009, 17th congress, Monterey, CA, USA, May 10th - 14h, 2009 |
|
[ISAM 05-09 07] Fuchs C, Eschrich B, Lim H, Pokorski R, Achtzehner W, Seemann S, Eismann C, Griese M and Knoch M
Monitoring Patient Adherence With a New Investigational eFlow Nebulizer System
International Society for Aerosols in Medicine, ISAM 2009, 17th congress, Monterey, CA, USA, May 10th 14th, 2009 |
|
[ISAM 05-09 06] Keller M, Egle R, Gruber F, Bitterle E, Fleschhut U, Denk O, Leuchte H, Behr J
Rationale For a Low Dose Liposomal Ciclosporin A For Inhalation via a Customized eFlow® electronic nebulizer to Prevent and Treat Bronchiolitis Obliterans (BO)
International Society for Aerosols in Medicine, ISAM 2009, 17th congress, Monterey, CA, USA, May 10th 14th, 2009 |
|
[ISAM 05-09 05] Keller M, Corbanie E, Fleschhut U, Maresch S, Bucholski A, Schuschnig U, Knoch M
Development of Highly Concentrated, Stable and Taste-Masked Aqueous Azithromycin Solutions for Nebulization
International Society for Aerosols in Medicine, ISAM 2009, 17th congress, Monterey, CA, USA, May 10th 14th, 2009 |
|
[ISAM 05-09 04] Tservistas M, Gallem T, Uhlig M, Seidler A, Waldner R, Seemann S, Keller M, and Knoch M
Evaluation of a Novel Electronic Nebulizer Utilizing a Customized Single Dose bfs-Ampoule to Improve Handling and Dosing Accuracy
International Society for Aerosols in Medicine, ISAM 2009, 17th congress, Monterey, CA, USA, May 10th 14th, 2009 |
|
[ISAM 05-09 03] Tservistas M, Fuchs C, Fleschhut U, Egle R, Reul K, Nikolai A, Uhlig M, Maresch S, Hochwimmer G, Keller M, and Knoch M
In Vitro Models to Investigate Aerosolized Surfactant Therapy For Premature Newborns Using a Novel Nebulizer Based on eFlow® Technology
International Society for Aerosols in Medicine, ISAM 2009, 17th congress, Monterey, CA, USA, May 10th 14th, 2009 |
|
[ISAM 05-09 02] Möller W, Schuschnig U, Meyer G, Häussinger K, Mentzel H and Keller M
Pulsating Aerosols Allow Topical Rhinosinusitis Therapy
International Society for Aerosols in Medicine, ISAM 2009, 17th congress, Monterey, CA, USA, May 10th - 14h, 2009 |
|
|
